Chr. Hansen Holding — Director's Dealing 2017

Apr 7, 2017

CHR HANSEN
Improving food & health
COMPANY ANNOUNCEMENT
NO.7/2017
7 April 2017

Managers' transactions

Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transaction related to shares in Chr. Hansen Holding A/S made by persons discharging managerial responsibilities in Chr. Hansen Holding A/S and/or persons closely related with them.

For further information please contact:

Anders Mohr Christensen, Senior Director, Investor Relations, Tel: +45 4574 7618
Camilla Lercke, Head of Media Relations, Tlf: +45 4574 7474

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Luis Cantarell
2	Reason for the notification
a)	Position/status	Board member
	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Chr. Hansen Holding A/S
b)	LEI	549300MKPW8ZF3E8MW37
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument identification code	Shares
DK 0060227585
b)	Nature of the transaction	Purchase of shares in Chr. Hansen Holding A/S
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 428.50	1,400
d)	Aggregated information
— Aggregated volume
— Price	1,400
428.50
e)	Date of the transaction	7 April 2017
f)	Place of the transaction	Nasdaq Copenhagen A/S

Manager's transactions
Chr. Hansen Holding A/S
Beoge Allé 10-12
DK-2970, Hoersholm
Denmark
Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677

---

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.

Manager's transactions

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970, Hoersholm
Denmark

Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677

Page 2/2